688321.SH
微芯生物
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 25.89
−7.37%Aug 19, 2026, 08:49 UTC
Chipscreen Biosciences reported its first-half 2026 results: net profit attributable to shareholders of 71.3806 million yuan, up 141.21% year-on-year.